Christopher J Hammett
Overview
Explore the profile of Christopher J Hammett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kedhi E, Windecker S, Latib A, Kirtane A, Kandzari D, Mehran R, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(5):100441.
PMID: 39131461
Background: Patients with diabetes mellitus (DM) are at a higher risk of ischemic events compared with patients without DM. Percutaneous coronary intervention (PCI) with the Resolute Onyx zotarolimus-eluting stent (ZES)...
2.
Chong D, Andreotti F, Verhamme P, Dalal J, Uaprasert N, Wang C, et al.
Eur Cardiol
. 2021 Jun;
16:e23.
PMID: 34135993
The disease burden of AF is greater in Asia-Pacific than other areas of the world. Direct oral anticoagulants (DOACs) have emerged as effective alternatives to vitamin K antagonists (VKA) for...
3.
Tavenier A, Hermanides R, Fabris E, Lapostolle F, Silvain J, Ten Berg J, et al.
Thromb Haemost
. 2019 Nov;
120(1):65-74.
PMID: 31752042
Background: Glycoprotein IIb/IIIa inhibitors (GPIs) in combination with clopidogrel improve clinical outcome in ST-elevation myocardial infarction (STEMI); however, finding a balance that minimizes both thrombotic and bleeding risk remains fundamental....
4.
Lapostolle F, Vant Hof A, Hamm C, Stibbe O, Ecollan P, Collet J, et al.
Am J Cardiovasc Drugs
. 2018 Oct;
19(2):173-183.
PMID: 30353444
Background: Morphine adversely impacts the action of oral adenosine diphosphate (ADP)-receptor blockers in ST-segment elevation myocardial infarction (STEMI) patients, and is possibly associated with differing patient characteristics. This retrospective analysis...
5.
Fabris E, Vant Hof A, Hamm C, Lapostolle F, Lassen J, Goodman S, et al.
Catheter Cardiovasc Interv
. 2018 Oct;
93(7):E369-E377.
PMID: 30302940
Objective: We investigated, in the contemporary era of ST-elevation myocardial infarction (STEMI) treatment, the influence of diabetes mellitus (DM) on cardiovascular outcomes, and whether pre-hospital administration of ticagrelor may affect...
6.
Bagai A, Goodman S, Cantor W, Vicaut E, Bolognese L, Cequier A, et al.
Am Heart J
. 2018 Feb;
196:56-64.
PMID: 29421015
Background: Among patients with STEMI in the ATLANTIC study, pre-hospital administration of ticagrelor improved post-PCI ST-segment resolution and 30-day stent thrombosis. We investigated whether this clinical benefit with pre-hospital ticagrelor...
7.
Hammett C, Amerena J, Brieger D, Sindone A, Thompson P, Worthley M, et al.
Curr Med Res Opin
. 2017 Dec;
34(3):551-558.
PMID: 29243497
Objective: There remain substantial gaps in implementation of evidence-based care in patients with acute coronary syndromes (ACS) in Australia, which contribute to high recurrent event rates. Improved translation of evidence...
8.
Fabris E, van t Hof A, Hamm C, Lapostolle F, Lassen J, Goodman S, et al.
Eur Heart J Acute Cardiovasc Care
. 2017 Aug;
8(3):208-217.
PMID: 28841028
Background: In the ATLANTIC (Administration of Ticagrelor in the catheterization laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery) trial the early use...
9.
Cayla G, Lapostolle F, Ecollan P, Stibbe O, Benezet J, Henry P, et al.
Int J Cardiol
. 2017 Jun;
244:49-53.
PMID: 28622941
Background: ATLANTIC was a randomized study comparing pre- and in-hospital treatment with a ticagrelor loading dose (LD) in ongoing ST-segment elevation myocardial infarction (STEMI). We sought to compare patient characteristics...
10.
Flaws D, Than M, Scheuermeyer F, Christenson J, Boychuk B, Greenslade J, et al.
Emerg Med J
. 2016 Jul;
33(9):618-25.
PMID: 27406833
Objective: The emergency department assessment of chest pain score accelerated diagnostic pathway (EDACS-ADP) facilitates low-risk ED chest pain patients early to outpatient investigation. We aimed to validate this rule in...